Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Learn the key factors to inspect when comparing funds, including costs, performance, and risk, to make informed investment choices.
18,792 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
VanEck's GENZ pivots from casino-heavy holdings to growth stocks like Uber and NetEase, reshaping its dividend story ...
Comcast plans to divide into two publicly traded entities, creating separate growth stories for NBCUniversal and the ...
Honeywell Aerospace begins trading as an independent company with a clear capital-allocation rule: invest in the supp...
A growing number of retirees are weighing a single-premium immediate annuity that pays $2,600 a month from a $400,000...
A major shakeup in AI deals spotlights coding as a premier use case for generative AI. Google hires Windsurf talent a...
Uber's growth engine is accelerating even as the stock trades in the low $70s, with analysts split on how quickly pro...
July 1 brought a sharp move for CoreWeave as a Bloomberg note about Meta expanding into cloud services rattled AI inf...
Two market behemoths, two roadmaps: Palantir’s enterprise AI software and SanDisk’s hyperscale memory hardware race t...
A deceptive message arrives as an urgent parking citation. Fort Wayne officials urge residents not to pay and to veri...
July 2026 offers a compelling setup for patient investors. Here’s my top-ranked stock for July, why it stands out, an...
Remote work holds steady around 22% of US workers in early 2026, defying headlines of a mass office return. New data ...